Pay in 4 interest-free payments of $7.26 Learn more
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16
Boost your confidence
The study also found that weight regain after stopping medication happened much faster than after weight loss achieved through diet and physical activity
[DOI] [PubMed] [Google Scholar] Janky R, Varga V, Oja SS, Saransaari P
Individuals with T2DM frequently have multiple cardiovascular risk factors, including obesity (32.9%), hypertension (32-80%), and dyslipidemia (39%) ( The association between glycemic control and cardiovascular outcomes in DM patients has been long studied ( To address these challenges, novel pharmacological therapies such as sodium-glucose cotransporter-2 inhibitors (SGLT-2i) and glucagon-like peptide-1 receptor agonists (GLP-1 RAs) have emerged, offering cardioprotective benefits ( The aim of this review is to enhance our understanding of the role of SGLT-2i and GLP-1 RAs in managing patients with T2DM and CVD
[9] References Droge, W
US$ 26.35
US$ 23.32
US$ 26.52
US$ 25.77
US$ 28.97
US$ 26.38
